Mukul Agrawal To Ashish Kacholia: What Makes Vasa Denticity Stock An Ace Investor Favourite?

Synopsis: Vasa Denticity is building a scalable dental supply platform by combining a wide product range, strong private labels, improving logistics, and offline expansion. Backed by experienced promoters and ace investors, the company is positioning itself as a long-term ecosystem play in an underpenetrated and growing dental market.

Some companies quietly build strong businesses in niche markets, long before they catch wider investor attention. When seasoned investors like Mukul Agrawal and Ashish Kacholia show interest in a relatively young company, it naturally raises curiosity about what they are seeing beneath the surface. Is it just early-stage growth, or is there a deeper, long-term story taking shape in India’s dental space?

About The Company

Vasa Denticity Ltd (VDL), was set up in 2016 by its promoters Dr Vikas Agarwal and Mr Sandeep Aggarwal. The company is involved in the sale and distribution of a wide range of dental products used for diagnosis, treatment, prevention, and cosmetic dental procedures.

The business operates mainly through its digital platform Dentalkart.com and the Dentalkart mobile app. Through these channels, Vasa Denticity supplies dental consumables, instruments, equipment, and accessories to dentists, dental clinics, and hospitals across India. 

Vasa Denticity functions as a B2B e-commerce marketplace and distributor focused on the dental segment. The company is listed on the NSE SME platform. In terms of shareholding, investor Ashish Kacholia holds a 3.51 percent stake in the company, while Mukul Mahavir Agrawal owns 2.36 percent. The shares of the company are trading at Rs. 600 with a market capitalization of Rs. 1,040.2 crore. 

What Makes Vasa Denticity An Ace Investor Favourite?

The Amazon of Dentistry

Vasa Denticity has built itself into a one-stop platform for dental professionals, much like how Amazon became indispensable in retail. The group operates across both online and offline channels and offers a very wide catalogue of more than 23,000 dental products sourced from around 300 domestic and international brands. Its online operations run through Dentalkart.com and the Dentalkart mobile app, which together cater to dentists, private clinics, hospitals, and medical colleges.

What strengthens this model is the promoters’ decade-long experience in the dental industry, their deep understanding of market behaviour, and long-standing relationships with suppliers and customers. This combination has helped the company steadily scale its ecosystem. In the first half of the year, the customer base expanded by 30 percent, with more than 2.7 lakh dental professionals now using the platform. During H1FY26 alone, 470 new brands were onboarded, further widening the product offering and reinforcing Dentalkart’s position as a default sourcing destination for dental needs.

Private Labels, Offline Expansion and Acquisitions

A key reason investors are tracking the business closely is the growing contribution from private labels. Nearly half of the company’s sales today come from its own brands, which gives it far better control over pricing, availability, and margins. Over time, these brands are expected to play an even larger role.

The acquisition of IDS Denmed adds another strong layer to this strategy. IDS Denmed is the largest offline dental distributor in India, built over nearly three decades, with a network of around 2,000 dealers and deep reach in smaller towns and cities. Management believes that even a decade from now, a large part of dental procurement will remain offline. Their internal estimate suggests that by 2032, around 40 percent of the market will move online, while 60 percent will still be offline.

Vasa Denticity began building its own offline presence around two years ago, and IDS Denmed is expected to significantly accelerate this effort. The acquisition is also expected to support margin improvement, particularly in equipment and instruments, by improving purchase efficiency. While consumables currently form the bulk of Dentalkart’s business, management sees equipment as critical for long-term growth. Consumables alone can scale only up to a point, whereas equipment sales help drive bundled demand and repeat consumable purchases.

IDS Denmed also brings a meaningful institutional sales presence. Although institutional business was lower this year compared to last year, management sees this segment benefiting over the long term through the expanded offline network. On pricing, the company believes its direct sourcing model allows it to offer products at prices that are typically 3-5 percent lower than most offline dealers.

The long-term objective is clear: make Dentalkart the first choice for clinics by offering faster delivery, wider selection, and reliable service. To support this, the company has already set up three service centres in India and is working to further improve turnaround times. While service timelines have improved over the past year, management acknowledges more work remains. The plan is to establish service centres in all Tier I cities within the next two years. The company also plans to use IDS Denmed’s 12 warehouses, all located in Tier I cities, to store products and enable faster deliveries. Over the next five to six years, management expects much deeper integration between the two businesses.

Inventory Is a Strategy, Not a Weakness

High inventory levels have drawn attention, but management views this as a deliberate choice rather than a structural issue. In a fragmented B2B market like dentistry, availability plays a central role in building trust. For Dentalkart, inventory is not just a balance sheet item but a promise to dentists that products will be available when needed.

The company has also introduced many products in India for the first time. New launches naturally require higher initial inventory since demand patterns take time to stabilise. Management prefers to accept some inefficiency in the short term rather than risk losing customers due to stock shortages. As data quality improves and demand patterns become clearer, inventory turns are expected to improve. The company believes that once scale and data reach a certain threshold, forecasting efficiency improves sharply.

In the near term, inventory days are expected to stabilise around 120 to 150 days, while over the longer term, management expects this to fall below 100 days. The focus for now remains on availability and customer retention, rather than short-term optimisation.

Margin Expansion Backed by Scale and Logistics

The group currently operates five warehouses across Haryana, Delhi, Mumbai, Bengaluru, Kolkata, Guwahati, and Chennai. Continued investments in logistics have already reduced average delivery time to 3.8 days in FY25 from 6.2 days in FY22, helping both customer acquisition and retention. In Q2FY26, average delivery time remained just under 4.2 days.

The share of revenue from the company’s own brands increased steadily to around 56 percent in FY25 from 46 percent in FY22. This shift helped improve operating margins to 9.2 percent from 7.4 percent over the same period. Margins dipped to around 5.3 percent in the first quarter of FY26 due to front-loaded spending on infrastructure, talent, and brand visibility. However, for the full year, margins are expected to return to the 9-10 percent range as scale improves and fixed costs get absorbed.

SEO, Content and Community-Led Growth

Vasa Denticity’s growth is increasingly being driven by organic discovery and community engagement. Total clicks rose from 2.87 lakh in Q1FY26 to 4.23 lakh in Q2FY26, a growth of 47 percent. Search impressions also increased from 18.8 million to 20.2 million during the same period, while average click-through rates improved from 1.5 percent to 2.1 percent, indicating better engagement and relevance.

Alongside SEO, the company is building what it aims to be India’s largest online dental community. Its approach combines paid and organic efforts, with a strong focus on knowledge-led content. This includes podcasts featuring dental experts, educational reels covering clinical tips and product demonstrations, and blogs and videos focused on new materials and technologies. Collaborations with key opinion leaders in dentistry have helped boost new user acquisition and strengthen trust through peer-led education.

Data-driven marketing has also played a key role. New user additions rose from 8,000 to 14,000 post campaigns, marking a 75 percent increase. Campaigns are segmented based on behaviour, engagement, and product interest, allowing targeted cross-selling, repeat purchases, and reactivation of inactive users. These efforts have supported higher average order values and sustained session growth across both sale and non-sale periods.

A Large and Underpenetrated Market Opportunity

The long-term opportunity remains sizable. India’s dental clinical supply market is expected to grow from USD 2.1 billion to USD 3.6 billion between 2023 and 2030, at a CAGR of 9.6 percent. The dental laboratory market is projected to expand from USD 1.4 billion to USD 3.1 billion over the same period, growing at around 12 percent annually. Digital dentistry is expected to grow at a CAGR of 9.1 percent between 2024 and 2032, yet penetration in India remains below 5 percent, compared to 39 percent in the US.

A key challenge in the market today is that many providers act only as product sellers, with limited post-installation support. Poor service experiences have slowed digital adoption among dentists, and integrated, long-term value-driven models remain largely absent. This gap is where Vasa Denticity is positioning itself.

Disciplined Product Launches and Tech Readiness

Product launches follow a disciplined approach. In underpenetrated categories with proven regional demand, the company works with manufacturers to expand availability nationwide. For completely new categories, management remains cautious, relying on pilots and regional data before scaling. The focus is on experimentation and validation rather than aggressive spending.

On the technology side, major upgrades to the app and website have already been completed, though improvements will remain ongoing as workflows are refined for dental-specific needs. From a capacity standpoint, the platform is already capable of handling nearly three times the current order volume. Significant fixed-cost investments in warehousing have also been completed in the first half, and these costs are not expected to rise in proportion with future order growth.

Conclusion

Vasa Denticity stands out because it is not just selling dental products but quietly building an ecosystem around dentists’ everyday needs. The combination of a wide product range, strong private labels, improving logistics, and a growing offline presence gives the business multiple levers for long-term growth. Its focus on availability, service quality, and education helps build trust with dentists, which is hard to replicate in a fragmented market. This steady, execution-driven approach is what makes the company attractive to long-term investors rather than short-term traders.

For ace investors like Mukul Agrawal and Ashish Kacholia, the appeal lies in the scale opportunity ahead and the discipline shown so far. The market is large, digital penetration is still low, and the company has already invested in systems, warehouses, and technology to support future growth. While near-term margins and inventory may fluctuate, the long-term thesis is centred on becoming the default platform for dental procurement in India. If execution continues as planned, Vasa Denticity has the potential to compound steadily over the coming years.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Mukul Agrawal To Ashish Kacholia: What Makes Vasa Denticity Stock An Ace Investor Favourite? appeared first on Trade Brains.